FDA accepts Bristol Myers Squibb's mezigdomide application for myeloma

July 13, 2026 6:59 AM

Bristol Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration has accepted a New Drug Application for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found